PE20220942A1 - COMPOSICION DE UN INHIBIDOR DE PI4KIIIalfa DE MOLECULA PEQUENA, METODO DE PREPARACION Y APLICACION DEL MISMO - Google Patents
COMPOSICION DE UN INHIBIDOR DE PI4KIIIalfa DE MOLECULA PEQUENA, METODO DE PREPARACION Y APLICACION DEL MISMOInfo
- Publication number
- PE20220942A1 PE20220942A1 PE2022000005A PE2022000005A PE20220942A1 PE 20220942 A1 PE20220942 A1 PE 20220942A1 PE 2022000005 A PE2022000005 A PE 2022000005A PE 2022000005 A PE2022000005 A PE 2022000005A PE 20220942 A1 PE20220942 A1 PE 20220942A1
- Authority
- PE
- Peru
- Prior art keywords
- present
- amount
- composition
- preparation
- inhibitor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/28—Compounds containing heavy metals
- A61K31/285—Arsenic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/12—Carboxylic acids; Salts or anhydrides thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Organic Chemistry (AREA)
- Neurosurgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
La presente invencion se refiere a una composicion farmaceutica que comprende: a) un inhibidor de fosfatidilinositol 4-quinasas (PI4KIIIalfa) de formula (I), donde: R1 es H, halogeno, nitro, entre otros y n es 0 a 5, en una cantidad entre 0.01 - 20 mg/g y b) un vehiculo farmaceuticamente aceptable que incluye un lipido, tal como un aceite vegetal, un acido graso, un fosfolipido, un esteroide, una vitamina liposoluble, entre otros, presente en una cantidad entre 50% p/p a 100% p/p del vehiculo. Adicionalmente, el vehiculo contiene: c) un antioxidante, tal como sulfito, bisulfito, entre otros, presente en una cantidad entre 0,001% - 5% en peso de la composicion farmaceutica y d) etanol presente en una cantidad de 10% a 0,1% (v/v). Tambien se refiere a un metodo de preparacion. La composicion de la presente invencion es util en el tratamiento de la enfermedad de Alzheimer (EA).
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2019094831 | 2019-07-05 | ||
| PCT/CN2020/100377 WO2021004422A1 (zh) | 2019-07-05 | 2020-07-06 | 小分子PI4KIIIα抑制剂组合物、其制备方法及用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PE20220942A1 true PE20220942A1 (es) | 2022-05-31 |
Family
ID=74115038
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PE2022000005A PE20220942A1 (es) | 2019-07-05 | 2020-07-06 | COMPOSICION DE UN INHIBIDOR DE PI4KIIIalfa DE MOLECULA PEQUENA, METODO DE PREPARACION Y APLICACION DEL MISMO |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US20230115711A1 (es) |
| EP (1) | EP3995134A4 (es) |
| JP (1) | JP2022538505A (es) |
| KR (1) | KR20220071175A (es) |
| CN (2) | CN118105372A (es) |
| AU (1) | AU2020309681A1 (es) |
| BR (1) | BR112022000155A2 (es) |
| CA (1) | CA3149104A1 (es) |
| CO (1) | CO2022001218A2 (es) |
| IL (1) | IL289586A (es) |
| MX (1) | MX2022000287A (es) |
| PE (1) | PE20220942A1 (es) |
| TW (1) | TW202126294A (es) |
| WO (1) | WO2021004422A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN114685566A (zh) * | 2020-12-31 | 2022-07-01 | 江苏挪贝肽医药科技有限公司 | 氧化苯砷晶型i、晶型ii和晶型iii及其制备方法 |
| WO2023051805A1 (zh) * | 2021-09-30 | 2023-04-06 | 挪贝肽医药科技(上海)有限公司 | 卤代氧化苯砷化合物及其应用 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030032203A1 (en) * | 2001-07-10 | 2003-02-13 | Sabatini David M. | Small molecule microarrays |
| EP2316943B1 (en) * | 2007-07-05 | 2013-06-19 | Novartis AG | DSRNA for treating viral infection |
| WO2016172952A1 (zh) * | 2015-04-30 | 2016-11-03 | 江苏挪贝肽医药科技有限公司 | PI4KIIIα蛋白及相关的膜蛋白复合体在治疗阿尔茨海默病中的应用 |
| EP3773734A4 (en) * | 2018-04-11 | 2022-05-11 | New Mexico Tech University Research Park Corporation | LIPID PRODRUGS FOR USE IN DRUG DELIVERY |
-
2020
- 2020-07-03 TW TW109122503A patent/TW202126294A/zh unknown
- 2020-07-06 CN CN202311755839.1A patent/CN118105372A/zh active Pending
- 2020-07-06 US US17/624,850 patent/US20230115711A1/en active Pending
- 2020-07-06 KR KR1020227003749A patent/KR20220071175A/ko unknown
- 2020-07-06 WO PCT/CN2020/100377 patent/WO2021004422A1/zh unknown
- 2020-07-06 CN CN202080049288.5A patent/CN114555056B/zh active Active
- 2020-07-06 CA CA3149104A patent/CA3149104A1/en active Pending
- 2020-07-06 MX MX2022000287A patent/MX2022000287A/es unknown
- 2020-07-06 JP JP2022526849A patent/JP2022538505A/ja active Pending
- 2020-07-06 BR BR112022000155A patent/BR112022000155A2/pt unknown
- 2020-07-06 EP EP20836327.5A patent/EP3995134A4/en active Pending
- 2020-07-06 AU AU2020309681A patent/AU2020309681A1/en active Pending
- 2020-07-06 PE PE2022000005A patent/PE20220942A1/es unknown
-
2022
- 2022-01-03 IL IL289586A patent/IL289586A/en unknown
- 2022-02-07 CO CONC2022/0001218A patent/CO2022001218A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| TW202126294A (zh) | 2021-07-16 |
| CA3149104A1 (en) | 2021-01-14 |
| AU2020309681A1 (en) | 2022-02-24 |
| WO2021004422A1 (zh) | 2021-01-14 |
| MX2022000287A (es) | 2022-06-16 |
| BR112022000155A2 (pt) | 2022-04-12 |
| CN114555056A (zh) | 2022-05-27 |
| EP3995134A1 (en) | 2022-05-11 |
| KR20220071175A (ko) | 2022-05-31 |
| EP3995134A4 (en) | 2023-07-12 |
| US20230115711A1 (en) | 2023-04-13 |
| CN118105372A (zh) | 2024-05-31 |
| CN114555056B (zh) | 2024-01-05 |
| CO2022001218A2 (es) | 2022-05-20 |
| IL289586A (en) | 2022-03-01 |
| JP2022538505A (ja) | 2022-09-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PE20220942A1 (es) | COMPOSICION DE UN INHIBIDOR DE PI4KIIIalfa DE MOLECULA PEQUENA, METODO DE PREPARACION Y APLICACION DEL MISMO | |
| BR112022024943A2 (pt) | Composição oral efervescente compreendendo um ingrediente ativo | |
| MA40111A1 (fr) | Dérivés du tétrahydronaphtalène inhibant la protéine mcl-1 | |
| AR108074A1 (es) | Composiciones de hormona esteroide en aceites de cadena media | |
| PA8622001A1 (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
| SG11201906708WA (en) | Stable and liposoluble active ingredient composition, microcapsule, and preparation method and application thereof | |
| ECSP066701A (es) | Derivados de sulfonamida para el tratamiento de enfermedades | |
| BR112013020167A2 (pt) | melhoradores de permeação para formulações tópicas | |
| BRPI0916936A8 (pt) | Composições farmacêuticas, uso de clevidipina e método de reduzir impurezas. | |
| PE20050138A1 (es) | Aceites de pescado con un perfil alterado de acidos grasos, un metodo para producir esos aceites y uso de ellos | |
| CL2022002564A1 (es) | Combinaciones de brimonidina de dosis baja y usos de las mismas. (solicitud divisional de 201903572) | |
| MX2022002548A (es) | Composiciones medicinales estables de cannabidiol. | |
| BR112023021160A2 (pt) | Lipídeos ionizáveis e composições para liberação em ácido nucleico | |
| BR0013385A (pt) | Composições farmacêuticas para administração oral e tópica | |
| TR201903470T4 (tr) | Kişisel hijyen için formülasyon. | |
| CA2739376A1 (en) | Stabilized composition for treating psoriasis | |
| BR112015028696A2 (pt) | composições de óleo estruturadas | |
| CO2022003583A2 (es) | Compuestos de curcumina y aminoácidos básicos | |
| UY33404A (es) | Composiciones farmacéuticas topicas | |
| JP2007169232A (ja) | 眼科用組成物 | |
| BR112017019753A2 (pt) | uso de composições de astaxantina, composição, processo para preparação de um produto alimentício ou ração, e, preparação medicinal | |
| PE20211483A1 (es) | Composiciones de acidos grasos poliinsaturados enriquecidos con ala | |
| PE20211198A1 (es) | Metodos y formulaciones para tratar nauseas y vomitos inducidos por quimioterapia | |
| AR097148A1 (es) | Composición alimenticia para rumiantes y método para prepararla | |
| CL2017002828A1 (es) | Composición para tratamiento de estrés oxidativo y enfermedad cardiovascular |